
IndraLab
Statements
reach
"In this work, we tested the binding capacities of compounds that had the strongest inhibition capacity to MAO B (1 and 4) to also bind into the small conductance calcium activated channel protein 1 (KCNN1), since this is a novel target for the treatment of neurological diseases through activation."